Heidi Health and Accurx Scribe should be compared through the documentation work available in the intended deployment, not an old assumption that one can write referrals and the other cannot. As of 22 September 2026, the practical questions concern customisation, record integration, review effort and the functions available through the clinician's actual account.
This comparison is published by iatroX and includes iatroX as a complementary reference and learning tool. iatroX is not an ambient scribe, and its free reference offer should not be confused with a replacement for clinical-record documentation.
At a Glance
Who is it for?
The original 2025 comparison positioned Heidi for power users and locums, and Accurx Scribe for standard GP users. That remains a useful description of the scenarios the page considered, not a restriction on who can use either product. The relevant question is whether a clinician needs extensive customisation, a familiar integrated workflow or both. The existing comparison, reviewed on 22 September 2026, is the source of that historical framing.
Why choose Heidi Health?
The original comparison highlighted custom templates, including a "Housing Support Letter", the ability to query a transcript through Ask Heidi with a question such as "Did the patient mention knee pain?", and greater control over headings and structure. It favoured Heidi for flexible output formatting. These are preserved as the page's 2025 product descriptions and editorial preferences, not a newly performed comparative test. The original page supplies those examples.
For a current decision, check the available template, transcript-query and output options in the relevant account. A sophisticated template is useful only if the final document accurately represents the encounter and remains easy to review.
Why choose Accurx Scribe?
The earlier page emphasised one-click saving into an EMIS or SystmOne consultation, minimal configuration and familiarity within the existing practice environment. It also asserted that Accurx was already information-governance approved by almost every ICB. That last statement lacks a defined denominator and supporting evidence in the original page, so it must not be treated as blanket approval for a new deployment. The 2025 comparison is the source of the historical claim.
Accurx's own partnership page, published on 27 May 2025 and checked on 22 September 2026, describes clinical-record write-back and currently uses Enlivio and SystmOne terminology. The original comparison used EMIS and SystmOne. Buyers should confirm the exact system and configuration rather than resolve entitlement from a familiar name alone. Accurx's announcement provides the first-party account.
Feature Comparison
The table preserves the dimensions of the original 2025 comparison, retrieved on 22 September 2026. Its historical descriptions are not a current entitlement matrix.
| Capability | Heidi in the original comparison | Accurx Scribe in the original comparison | September 2026 interpretation |
|---|---|---|---|
| Workflow | Mostly copy and paste | Direct save | Verify the actual integration; do not assume Heidi always requires manual transfer |
| Features | Chat, templates and multilingual use | Core note generation | The Accurx description was too narrow: its own announcement also describes referrals and communications |
| Flexibility | Any setting or specialty | Optimised for GP use | Treat this as original positioning, not a guarantee of equal suitability across all specialties |
The original table is preserved in substance from the existing page. The correction to the narrow Accurx feature description follows its published partnership announcement, which describes referral letters, Advice and Guidance requests, appointment summaries and follow-up messages as well as documentation.
In-Depth Analysis
Overview
The earlier overview used an "Apple" analogy for Accurx's simple, integrated experience and a "Pro" analogy for Heidi's flexibility. It said Accurx would be enough for 80% of GPs. That percentage was an editorial assertion without a disclosed survey, denominator or method; it is not evidence of user preference or product adequacy. The original overview is the source.
The same overview described turning a consultation transcript into a formal referral letter, housing report and clinical note simultaneously with Heidi, while suggesting Accurx could not do that work. The multi-document example remains useful, but the exclusion is unsupported: Accurx's own 27 May 2025 announcement already described referral generation and other outputs. The comparative claim was therefore overbroad. Accurx's description supports the correction without establishing that the products offer identical customisation.
The practical distinction is between the exact output and handover each product supports. "Can draft a referral" and "can produce the required set of reviewed documents with minimal transfer" are not the same requirement.
Key Differences
The original recommendation was Accurx for speed and convenience, Heidi for referral letters and broader administrative customisation. As a scenario-based judgement, that remains a useful question to test. It should not be presented as an established universal performance ranking or a claim that referral generation is exclusive to Heidi.
For a fair current comparison, use the same synthetic encounter and required outputs. Record what must be edited, which formatting choices are available, how the approved content enters the record and whether any information is lost between documents. No such comparative run was performed for this update.
Looking for a faster way?
The original section introduced iatroX as a free AI-driven alternative for rapid UK guideline retrieval and examination preparation. The correct distinction is that it is an alternative way to access clinical reference and learning, not an alternative scribe. Per iatroX product information, September 2026, Ask-iatroX is free without trial expiry or a verification gate and links to source material grounded in NICE, CKS, SIGN and SmPC information from emc.
Free question access is also available. The separate paid subscription combines question banks, Socratic Tutor, study planning, simulations and CPD tools. A clinician may therefore use a documentation product for the encounter and iatroX for a guideline question or structured revision afterwards.
Use-Cases
Standard 10min Appt
When to choose Heidi Health
The original example described Heidi as useful but requiring a copy-and-paste step. For the fictional standard ten-minute appointment, that remains a workflow detail to verify rather than a permanent property of every Heidi deployment. Check the approved local integration and compare the complete review-and-save process.
When to choose Accurx Scribe
The original page favoured Accurx because direct saving could make a standard GP consultation easier to complete. This is a reasonable scenario-based preference where the local deployment provides that function and the generated note meets the clinician's needs. It is not a measured speed result from this update.
Complex Mental Health
When to choose Heidi Health
The earlier scenario favoured a custom mental-health template for structuring a long note. Retain that problem: a fictional complex consultation may need clear separation of the patient's account, uncertainty, agreed actions and follow-up. A custom template is worth considering where it makes those distinctions easier to review rather than merely making the note longer.
When to choose Accurx Scribe
The original page described a generic block of text that might need manual reformatting. That is retained as a historical concern, not a current claim about every Accurx output. Test the available templates and output structure before deciding that the present product cannot meet the requirement.
What the September funding changes
Heidi's announcement on 22 September 2026 describes a US$100 million Series C and US$240 million growth investment. Tandem, whose technology underlies Accurx Scribe, announced US$100 million Series B equity on 14 September 2026. Those events add strategic context, not an automatic change to an Accurx deployment or a Heidi subscription. Heidi's announcement, Tandem's announcement and Accurx's partnership explanation establish the respective relationships.
Heidi's forthcoming capabilities in the new announcement are not being made available in the UK and EU. That qualification concerns those capabilities, not all existing Heidi services. Buyers should compare what they can deploy now, not an imagined combination of every roadmap item. The Heidi release provides the regional boundary.
Verdict by reader scenario
For a GP satisfied with an approved Accurx workflow, direct review and saving may be the most useful starting point. For a clinician with demanding multi-document or template requirements, evaluate Heidi's current configuration alongside Accurx's available outputs. For the mental-health scenario, compare faithful structure rather than assuming a brand-specific winner. For UK clinical reference or revision, iatroX addresses a separate need alongside either scribe.
Frequently asked questions
Can Accurx Scribe generate referral letters?
Accurx's 27 May 2025 partnership announcement describes referral letters and Advice and Guidance requests alongside documentation. Exact functionality still needs checking in the local deployment.
Does Heidi always require copying and pasting?
That was the original 2025 page's broad workflow description, not a universal claim for September 2026. Confirm the integration and transfer process for the account and clinical system being considered.
Is iatroX an alternative ambient scribe?
No: its role in this comparison is free clinical reference and structured learning. It can complement either documentation workflow without replacing its recording or record-transfer functions.